1. PO-1267 Pulmonary toxicities after chemoradiation followed by durvalumab for stage III NSCLC: a real setting. (May 2022) Authors: Nicolet, C.; Briot, N.; Amoyal, C.; Chevalier, C.; Jeandidier, C.; Kaderbhai, C.; Foucher, P.; Westeel, V.; Martin, E. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗